Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Conversion Efficiency

Latest as of June 2023: 0.059x

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow conversion efficiency. Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (GU5) has a cash flow conversion efficiency ratio of 0.059x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€2.10 Billion ≈ $2.45 Billion USD) by net assets (€35.38 Billion ≈ $41.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

Cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guangzhou Baiyunshan Pharmaceutical Hold share price for real-time trading data and today's change.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Cash Flow Conversion Ratio Explained

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited ranked by their cash flow conversion efficiency. Also see market cap of Guangzhou Baiyunshan Pharmaceutical Hold for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Duratec Ltd AU:DUR	0.215x
Lux Industries Limited NSE:LUXIND	-0.125x
CMS Info Systems Limited NSE:CMSINFO	-0.050x
Hillstone Networks Co Ltd SHG:688030	-0.042x
Guangzhou Seagull Kitchen And Bath Products Co Ltd SHE:002084	0.042x
Yantai Zhenghai Bio-Tech Co Ltd SHE:300653	0.034x
Ashot Ashkelon Industries Ltd TA:ASHO	0.059x
D-Link Corp TW:2332	-0.022x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (2013–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited from 2013 to 2025. Review cash generation quality of Guangzhou Baiyunshan Pharmaceutical Hold to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€40.08 Billion ≈ $46.86 Billion	€-232.46 Million ≈ $-271.77 Million	-0.006x	-106.36%
2024-12-31	€37.77 Billion ≈ $44.16 Billion	€3.44 Billion ≈ $4.02 Billion	0.091x	-18.54%
2023-12-31	€36.68 Billion ≈ $42.88 Billion	€4.10 Billion ≈ $4.80 Billion	0.112x	-46.23%
2022-12-31	€33.64 Billion ≈ $39.33 Billion	€7.00 Billion ≈ $8.18 Billion	0.208x	+14.89%
2021-12-31	€31.33 Billion ≈ $36.62 Billion	€5.67 Billion ≈ $6.63 Billion	0.181x	+772.92%
2020-12-31	€28.21 Billion ≈ $32.97 Billion	€585.19 Million ≈ $684.14 Million	0.021x	-89.26%
2019-12-31	€25.99 Billion ≈ $30.38 Billion	€5.02 Billion ≈ $5.87 Billion	0.193x	-14.27%
2018-12-31	€23.14 Billion ≈ $27.06 Billion	€5.22 Billion ≈ $6.10 Billion	0.225x	+136.80%
2017-12-31	€19.26 Billion ≈ $22.52 Billion	€1.83 Billion ≈ $2.14 Billion	0.095x	-33.96%
2016-12-31	€17.65 Billion ≈ $20.64 Billion	€2.54 Billion ≈ $2.97 Billion	0.144x	-35.54%
2015-12-31	€8.68 Billion ≈ $10.15 Billion	€1.94 Billion ≈ $2.27 Billion	0.224x	+1.31%
2014-12-31	€7.92 Billion ≈ $9.26 Billion	€1.75 Billion ≈ $2.04 Billion	0.221x	+15.99%
2013-12-31	€7.02 Billion ≈ $8.21 Billion	€1.34 Billion ≈ $1.56 Billion	0.190x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited

F:GU5 Germany Medical Distribution

Market Cap

$365.06 Million

€312.26 Million EUR

Market Cap Rank

#13551 Global

#1412 in Germany

Share Price

€1.42

Change (1 day)

+0.71%

52-Week Range

€1.41 - €2.30

All Time High

€2.30